Rs involving TOP1 inhibitors, Topotecan and Irinotecan. (XLSX) Table S4 Overlap
Rs between TOP1 inhibitors, Topotecan and Irinotecan. (XLSX) Table S4 Overlap of PC-Meta markers among MEK inhibitors, PD-0325901 and AZD6244, and reported signature in . (XLSX) Table S5 List of…